COMP <GO>
IMAX vs PG // REVENUE GROWTH (YOY)
Imax Corporation (NYSE) VS. Procter & Gamble Company (NYSE) • 15-METRIC TALLY: IMAX 4
— PG 8
▲ REVENUE GROWTH (YOY) LEADER: IMAX
LAST: $50.61 (-1.42%) • MKT CAP: $2.82B
revenue-growth
16.50%
LAST: $161.57 (+0.61%) • MKT CAP: $372.21B
revenue-growth
0.30%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (IMAX VS. PG)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | IMAX | PG | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 60.00% | 51.20% | +8.80 | IMAX | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 35.60% | 25.40% | +10.20 | IMAX | /roic <GO> |
| EV/EBITDA & P/E Valuation | 29.2x | 16.2x | +13.00 | PG | /valuation <GO> |
| Free Cash Flow Yield | 4.22% | 3.77% | +0.45 | IMAX | /fcf-yield <GO> |
| Operating Margin | 20.50% | 24.30% | -3.80 | PG | /operating-margins <GO> |
| Net Profit Margin | 8.50% | 19.00% | -10.50 | PG | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | 16.50% | 0.30% | +16.20 | IMAX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.65% | -2.65 | PG | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.02 | 5.59 | -1.57 | PG | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 47.2 | 60.3 | -13.10 | PG | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.87 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 67.8x | 21.7x | +46.10 | PG | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.82B | $372.21B | -$369.40B | PG | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | IMAX REV | PG REV | IMAX GROSS % | PG GROSS % | IMAX FCF | PG FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $410.2M | $84.28B | 60.0% | 51.2% | $118.9M | $14.04B |
| FY 2024 | $352.2M | $84.04B | 54.0% | 51.4% | $62.4M | $16.52B |
| FY 2023 | $374.8M | $82.01B | — | — | $58.6M | $13.16B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
IMAX // BETA —
PG // BETA 0.87